TrialCancer medicine2021

Efficacy and safety of sorafenib plus vitamin K treatment for hepatocellular carcinoma: A phase II, randomized study.

Yoshimichi Haruna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.